Clinical Trials for Samjin Pharm

Explore 9 clinical trials worldwide

Showing 1-9 of 9 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Samjin Pharm

Clinical Trials (9)

Comparison of Pitavastatin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus

PHASE4Recruiting

2,000 participants

Started: Apr 25, 2025 · Completed: Jan 31, 2030

3 conditions3 sponsors1 location

Clopidogrel Versus Cilostazol on Vessels

PHASE4Recruiting

120 participants

Started: Apr 16, 2024 · Completed: Dec 31, 2027

2 conditions2 sponsors1 location

Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin As Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE

PHASE4Recruiting

200 participants

Started: Feb 20, 2024 · Completed: Mar 31, 2029

6 conditions2 sponsors32 locations

Pill-in-the-POCKET Oral Anticoagulation Strategy After AF Catheter Ablation

400 participants

Started: Feb 1, 2024 · Completed: Dec 31, 2030

1 condition3 sponsors1 location

Safety and Efficacy of AR1005 in Patients with Lewy Body Disease

PHASE2Recruiting

60 participants

Started: Jan 1, 2024 · Completed: Dec 31, 2025

1 condition3 sponsors1 location

Ticagrelor De-escalation Strategy in AMI Patients

PHASE4Recruiting

2,312 participants

Started: Mar 27, 2023 · Completed: Jan 31, 2028

1 condition3 sponsors1 location

Mobile App for Improving Adherence of Rivoxaban (RIVOX-AF)

1,042 participants

Started: Mar 10, 2022 · Completed: Dec 31, 2025

1 condition2 sponsors1 location

Deferred Stenting in Patients With Anterior Wall STEMI

NAActive, not recruiting

185 participants

Started: Apr 3, 2018 · Completed: Nov 30, 2025

2 conditions3 sponsors1 location

Consolidation Chemotherapy for Locally Advanced Mid or Low Rectal Cancer After Neoadjuvant Concurrent Chemoradiotherapy

PHASE3Active, not recruiting

358 participants

Started: Dec 7, 2016 · Completed: Jun 30, 2026

1 condition6 sponsors14 locations